Literature DB >> 19364075

Porcine endogenous retrovirus (PERV) and its transmission characteristics: a study of the New Zealand designated pathogen-free herd.

O Garkavenko1, S Wynyard, D Nathu, D Simond, M Muzina, Z Muzina, L Scobie, R D Hector, M C Croxson, P Tan, B R Elliott.   

Abstract

Previously a strategy for monitoring of pigs intended for cell transplantation was developed and successfully applied to several representative herds in New Zealand. A designated pathogen-free (DPF) herd has been chosen as a good candidate for xenotransplantation. This herd has previously tested free of infectious agents relevant to xenotransplantation and we present here an in depth study of porcine endogenous retrovirus (PERV) transmission. A panel of assays that describes the constraints for the transmission of PERV has been suggested. It includes a) infectivity test in coculture of DPF pig primary cells with both human and pig target cell lines; b) RT activity in supernatant of stimulated primary cells from DPF pigs; c) viral load in donor's blood plasma; d) PERV proviral copy number in DPF pig genome; e) PERV class C prevalence in the herd and its recombination potential. There was no evidence of PERV transmission from DPF pig tissue to either pig or human cells. Additionally, there was no evidence of PERV RNA present in pig blood plasma. PERV copy number differs in individual pigs from as low as 3 copies to 30 copies and the presence of PERV-C varied between animals and breeds. In all DPF pigs tested, a specific locus for PERV-C potentially associated with the recombination of PERV in miniature swine was absent. Presented data on the PERV transmission allows us to classify the DPF potential donors as "null" or noninfectious pigs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19364075     DOI: 10.3727/096368908787648056

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

Review 1.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

2.  Xenotransplantation-associated infectious risk: a WHO consultation.

Authors:  Jay A Fishman; Linda Scobie; Yasuhiro Takeuchi
Journal:  Xenotransplantation       Date:  2012 Mar-Apr       Impact factor: 3.907

3.  Infection in xenotransplantation: opportunities and challenges.

Authors:  Jay A Fishman
Journal:  Curr Opin Organ Transplant       Date:  2019-10       Impact factor: 2.640

4.  Biomanufacturing of Axon-Based Tissue Engineered Nerve Grafts Using Porcine GalSafe Neurons.

Authors:  Kritika S Katiyar; Justin C Burrell; Franco A Laimo; Kevin D Browne; John R Bianchi; Anneke Walters; David L Ayares; Douglas H Smith; Zarina S Ali; Harry C Ledebur; D Kacy Cullen
Journal:  Tissue Eng Part A       Date:  2021-04-09       Impact factor: 4.080

5.  Extended Microbiological Characterization of Göttingen Minipigs in the Context of Xenotransplantation: Detection and Vertical Transmission of Hepatitis E Virus.

Authors:  Vladimir A Morozov; Alexey V Morozov; Avi Rotem; Uriel Barkai; Stefan Bornstein; Joachim Denner
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

Review 6.  Virus Safety of Xenotransplantation.

Authors:  Joachim Denner
Journal:  Viruses       Date:  2022-08-30       Impact factor: 5.818

Review 7.  Why was PERV not transmitted during preclinical and clinical xenotransplantation trials and after inoculation of animals?

Authors:  Joachim Denner
Journal:  Retrovirology       Date:  2018-04-02       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.